Biosimilar medicines are highly similar to reference medicines without differences in safety, purity or efficacy Biosimilars or biosimilar medicines are the key to guaranteeing a competitive pharmacological market, with reasonable prices and capable of rivaling conventional medicines. They can compete with these when they are no longer protected by patent law. Thus, a biosimilar is

Horizon 2030 covers innovation in medicines, sustainability in their production and global collaboration to improve the health and well-being of world’s population Horizon 2030 directly influences environmental, social and governmental criteria. Hence, we must work for the technological and sustainable development of the pharmaceutical industry. The pharmaceutical and healthcare sectors have always played a fundamental

The aim is to promote innovation in the pharmaceutical industry and guarantee supply, accessibility and affordability of medicines On April 10, the plenary session of the European Parliament approved the renewal of pharmaceutical legislation, based on a proposal from the European Union. In this way, the aim is to promote innovation in the pharmaceutical industry

Pharmaceutical research requires greater investment and logistical support for the development of the sector and to face the new health challenges of the future International cooperation is essential in R&D within the pharmaceutical industry and research. The exchange of knowledge on an increasingly global scale, between public entities, administrations, research centers, health centers, universities and

After the pandemic, the pharmaceutical industry has experienced a boom that is not exempt from challenges that it must currently solve Once the COVID-19 pandemic was over, the pharmaceutical industry achieved greater recognition around the world. Not only among the general population, but also for governments and international institutions to allocate funds to the research

Pharmacovigilance aims to identify, quantify, evaluate and prevent risks associated with medications or vaccines With pharmacovigilance, adverse reactions or any other health problem related to drugs or vaccines are detected, evaluated and prevented. The objective of pharmacovigilance is to report adverse effects of medications at any time during their production and also during their consumption,

Spain is a producing country, it has initiated the procedures to approve the regulation of medical cannabis, but it has not yet legalized its therapeutic use The Spanish Agency for Medicines and Health Products (AEMPS), dependent on the Ministry of Health, has notified the International Narcotics Control Board of a production forecast of 36 tons

The development of vaccines, innovations and projects that address problems such as cancer, some viruses and diseases without a vaccine have been launched In a recent study by Vaccines Europe, it emphasized how important it is to continue researching and developing vaccines. And since Covid-19 it has become clear that, in a very short time,

What are nitrosamines and continuous control of nitrosamines in the pharmaceutical industry Nitrosamines are defined as organic compounds that have a nitrous functional group, which can be present in routine foods (meats, vegetables and dairy products), in common consumer products (cosmetics, plastics, rubber and even personal hygiene products) and in medicines. For this reason, the

The Spanish Ministry of Health has announced the beginning of the procedures to develop the Decree that approves the regulation of medical cannabis The Spanish Ministry of Health has recently announced the opening of the procedures for the development of the Royal Decree with which the regulation of cannabis for medical use will be approved.